BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents

Breast cancer type 2 susceptibility (BRCA2) protein is crucial for initiating DNA damage repair after chemotherapy with DNA interstrand crosslinking agents or X-ray irradiation, which induces DNA double-strand breaks. BRCA2 contains a C-terminal RAD51-binding domain (CTRBD) that interacts with RAD51...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zida, Kitano, Taisuke, Morimatsu, Masami, Tanaka, Arisa, Morioka, Ryo, Lin, Xianghui, Orino, Koichi, Yoshikawa, Yasunaga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000072/
https://www.ncbi.nlm.nih.gov/pubmed/35409418
http://dx.doi.org/10.3390/ijms23074060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000072/
https://www.ncbi.nlm.nih.gov/pubmed/35409418
http://dx.doi.org/10.3390/ijms23074060

Ejemplares similares